Courtney Leonard,
“ASCO is always magical. One of the reasons is that behind every data slide and headline, there’s a patient, a family, and a story.
For me, pancreatic cancer is personal. I lost my dad to the disease far too soon, (who was known for many things, including a legendary head of hair!)– so seeing one of the biggest stories from ASCO 2026 come from pancreatic cancer felt especially meaningful.
After the presentation of the RASolute-302 data, The Oncology Brothers sat down with leading experts and investigators to discuss what these findings mean for patients and for community oncology practice.
While there’s still a long way to go, moments like this offer something that pancreatic cancer has needed more of: hope.
Most importantly, congratulations to the patients, families, investigators, and study teams who made this progress possible.
Check out the discussion here.”